Prescription drug · ANDA
Cefixime 400 mg (cefixime) NDC 83112-400
Cefixime 400 mg/1 · Capsule · Oral · Health Department, Oklahoma State
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 83112-400-00 | 83112040000 | 2 CAPSULE in 1 PACKET (83112-400-00)Marketed from Oct 12, 2018 | |
| 83112-400-02 | 83112040002 | 2 CAPSULE in 1 PACKET (83112-400-02)Marketed from Oct 12, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Cefixime 400 mg
- Generic name (nonproprietary)
- cefixime
- Active ingredients
- Cefixime — 400 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 210574
- Marketing start
- Listing expires
- Other FDA classes
- Cephalosporins (Chemical structure)
- Identifiers
- Product ID 83112-400_466300ca-f48d-6568-e063-6294a90ac2a0SPL ID 466300ca-f48d-6568-e063-6294a90ac2a0SPL set ID f0fdb14b-e4fb-707e-e053-2a95a90a9049RxCUI 409823UNII 97I1C92E55
- Pharmacologic class
- Cephalosporin Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N483112040000followed by a unit qualifier and the quantityPackage 83112-0400-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 210574
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.